Zydus Cadila receives final approval from US FDA for Mesalamine Extended-Release capsules
The capsules are indicated for the maintenance of remission of ulcerative colitis in adults
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Michael Ertl to head Inorganic Pigments business unit at LANXESS
Ertl succeeds Holger Hueppeler (53), who heads the newly-formed Flavours & Fragrances (F&F) business unit following the…
Serum Institute of India (SII) acquires 50 per cent stake of SCHOTT Kaisha
With this acquisition, Serum is securing its supply of high-quality pharma packaging amid rising global demand
Panacea Infosec India and Healmed Solutions USA form joint venture ‘Panacea Healmed’
India’s first Artificial Intelligence (AI)-powered digital, touch-free, voice-enabled interface aiming to disrupt and transform…
Venus Remedies Q1 net profit records 629.5 per cent increase
Propelled by robust sales, the company’s net profit increased to Rs 14.59 crores in the first quarter of FY 2021-22 from Rs 2…
Lupin receives tentative US FDA approval for Brivaracetam tablets
The product will be manufactured at Lupin’s Nagpur facility in India
Centre to mandatorily revise ceiling prices of drugs every five years
The order is with regard to the Indian Drugs Manufacturers Association's (IDMA) views on notification No. S.O. 3249 (E), dated…
Indian Immunologicals produces Covaxin drug substance
The output of Covaxin drug substance will be three-to-four million a month, and from December, will increase to 10 million a month
Swastika Investmart signs MoU with Medcords Healthcare Solutions to accelerate growth of retail…
The two companies have together launched a finance scheme for ‘Sehat Sathi App’-registered medical stores
Looking to Refresh your Dissolution Lab?
From qualification to reporting, Agilent Dissolution Solutions is the answer.
With a rich history in supporting the…